JP2021522219A5 - - Google Patents

Info

Publication number
JP2021522219A5
JP2021522219A5 JP2020558587A JP2020558587A JP2021522219A5 JP 2021522219 A5 JP2021522219 A5 JP 2021522219A5 JP 2020558587 A JP2020558587 A JP 2020558587A JP 2020558587 A JP2020558587 A JP 2020558587A JP 2021522219 A5 JP2021522219 A5 JP 2021522219A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
use according
administered
tafluprost
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020558587A
Other languages
English (en)
Japanese (ja)
Other versions
JP7855312B2 (ja
JP2021522219A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/060455 external-priority patent/WO2019206956A1/en
Publication of JP2021522219A publication Critical patent/JP2021522219A/ja
Publication of JP2021522219A5 publication Critical patent/JP2021522219A5/ja
Application granted granted Critical
Publication of JP7855312B2 publication Critical patent/JP7855312B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020558587A 2018-04-27 2019-04-24 緑内障の治療のためのタフルプロストを含む眼科用組成物 Active JP7855312B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18169920.8 2018-04-27
EP18169920 2018-04-27
PCT/EP2019/060455 WO2019206956A1 (en) 2018-04-27 2019-04-24 Ophthalmic compositions comprising tafluprost for the treatment of glaucoma

Publications (3)

Publication Number Publication Date
JP2021522219A JP2021522219A (ja) 2021-08-30
JP2021522219A5 true JP2021522219A5 (https=) 2022-04-21
JP7855312B2 JP7855312B2 (ja) 2026-05-08

Family

ID=

Similar Documents

Publication Publication Date Title
JP2025176189A5 (https=)
JP2021518352A5 (https=)
JP2020535156A5 (https=)
JP7250728B2 (ja) 局所投与方法
IL273531B1 (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
CN102652022B (zh) 治疗干眼综合征的药物组合物
IL276888B2 (en) Pharmaceutical composition comprising timolol
Sambhara et al. Glaucoma management: relative value and place in therapy of available drug treatments
JP2022546980A5 (https=)
JP2018531233A5 (https=)
CN119546278A (zh) 两性离子在眼用局部乳膏组合物和制剂中的新应用
KR20150014966A (ko) 안과용 전달 시스템
MX2012010684A (es) Composicion farmaceutica para el tratamiento de la presion intraocular incrementada.
US4278664A (en) Preventative treatment for Otitis externae
JP6992033B2 (ja) ソフトコンタクトレンズの変質を抑制する眼科用組成物
KR20140013013A (ko) 안검하수증의 비-외과적 치료를 위한 조성물 및 방법
CA2705050A1 (en) Compositions for the treatment and prevention of eyelid swelling
AU2023208076A1 (en) Fixed dose combination of brimonidine and timolo
TW200815410A (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
CN1993118B (zh) 促进眼内渗透性的水性滴眼剂
TWI410252B (zh) 用以治療或控制前段炎症之組合物及方法
JP2021522219A5 (https=)
JP4966854B2 (ja) キサンタンガムおよびテルペノイドを含有する点眼剤
JP5513702B2 (ja) 抗菌点眼剤
JP5738839B2 (ja) 薬剤のあらかじめ決定された複数回用量を送達するための複数回用量パッケージ、治療コースおよび治療法